Jinyao Pharmaceutical: Dexamethasone bulk drug approved for marketing
2026-11-19 15:51:34
According to CoinMeta, on November 19th, Jinyao Pharmaceutical announced that the company had received the 'Approval Notice for the Marketing Application of Dexamethasone as a Chemical Raw Drug' issued by the National Medical Products Administration. This drug is mainly used for allergic and autoimmune inflammatory diseases.
Bullish 0
Bearish 0
Source:Jin10 Data
This content is for market information only and does not constitute investment advice.